Identification of residual tumor with intraoperative contrast-enhanced ultrasound during glioblastoma resection

Francesco Prada, Massimiliano Del Bene, Riccardo Fornaro, Ignazio G. Vetrano, Alberto Martegani, Luca Aiani, Luca Maria Sconfienza, Giovanni Mauri, Luigi Solbiati, Bianca Pollo, Francesco DiMeco

Research output: Contribution to journalArticle

Abstract

Objective The purpose of this study was to assess the capability of contrast-enhanced ultrasound (CEUS) to identify residual tumor mass during glioblastoma multiforme (GBM) surgery, to increase the extent of resection. Methods The authors prospectively evaluated 10 patients who underwent surgery for GBM removal with navigated ultrasound guidance. Navigated B-mode and CEUS were performed prior to resection, during resection, and after complete tumor resection. Areas suspected for residual tumors on B-mode and CEUS studies were localized within the surgical field with navigated ultrasound and samples were sent separately for histopathological analysis to confirm tumor presence. Results In all cases tumor remnants were visualized as hyperechoic areas on B-mode, highlighted as CEUS-positive areas, and confirmed as tumoral areas on histopathological analysis. In 1 case only, CEUS partially failed to demonstrate residual tumor because the residual hyperechoic area was devascularized prior to ultrasound contrast agent injection. In all cases CEUS enhanced B-mode findings. Conc lusions As has already been shown in other neoplastic lesions in other organs, CEUS is extremely specific in the identification of residual tumor. The ability of CEUS to distinguish between tumor and artifacts or normal brain on B-mode is based on its capacity to show the vascularization degree and not the echogenicity of the tissues. Therefore, CEUS can play a decisive role in the process of maximizing GBM resection.

Original languageEnglish (US)
Article numberE7
JournalNeurosurgical Focus
Volume40
Issue number3
DOIs
StatePublished - Mar 1 2016

Fingerprint

Residual Neoplasm
Glioblastoma
Neoplasms
Artifacts
Contrast Media
Injections
Brain

Keywords

  • Contrast-enhanced ultrasound
  • Extent of resection
  • Glioblastoma
  • Intraoperative imaging
  • Intraoperative ultrasound
  • Residual tumor

ASJC Scopus subject areas

  • Surgery
  • Clinical Neurology

Cite this

Prada, F., Del Bene, M., Fornaro, R., Vetrano, I. G., Martegani, A., Aiani, L., ... DiMeco, F. (2016). Identification of residual tumor with intraoperative contrast-enhanced ultrasound during glioblastoma resection. Neurosurgical Focus, 40(3), [E7]. https://doi.org/10.3171/2015.11.FOCUS15573

Identification of residual tumor with intraoperative contrast-enhanced ultrasound during glioblastoma resection. / Prada, Francesco; Del Bene, Massimiliano; Fornaro, Riccardo; Vetrano, Ignazio G.; Martegani, Alberto; Aiani, Luca; Sconfienza, Luca Maria; Mauri, Giovanni; Solbiati, Luigi; Pollo, Bianca; DiMeco, Francesco.

In: Neurosurgical Focus, Vol. 40, No. 3, E7, 01.03.2016.

Research output: Contribution to journalArticle

Prada, F, Del Bene, M, Fornaro, R, Vetrano, IG, Martegani, A, Aiani, L, Sconfienza, LM, Mauri, G, Solbiati, L, Pollo, B & DiMeco, F 2016, 'Identification of residual tumor with intraoperative contrast-enhanced ultrasound during glioblastoma resection', Neurosurgical Focus, vol. 40, no. 3, E7. https://doi.org/10.3171/2015.11.FOCUS15573
Prada, Francesco ; Del Bene, Massimiliano ; Fornaro, Riccardo ; Vetrano, Ignazio G. ; Martegani, Alberto ; Aiani, Luca ; Sconfienza, Luca Maria ; Mauri, Giovanni ; Solbiati, Luigi ; Pollo, Bianca ; DiMeco, Francesco. / Identification of residual tumor with intraoperative contrast-enhanced ultrasound during glioblastoma resection. In: Neurosurgical Focus. 2016 ; Vol. 40, No. 3.
@article{939e628fca164fdd95f41d43e591560b,
title = "Identification of residual tumor with intraoperative contrast-enhanced ultrasound during glioblastoma resection",
abstract = "Objective The purpose of this study was to assess the capability of contrast-enhanced ultrasound (CEUS) to identify residual tumor mass during glioblastoma multiforme (GBM) surgery, to increase the extent of resection. Methods The authors prospectively evaluated 10 patients who underwent surgery for GBM removal with navigated ultrasound guidance. Navigated B-mode and CEUS were performed prior to resection, during resection, and after complete tumor resection. Areas suspected for residual tumors on B-mode and CEUS studies were localized within the surgical field with navigated ultrasound and samples were sent separately for histopathological analysis to confirm tumor presence. Results In all cases tumor remnants were visualized as hyperechoic areas on B-mode, highlighted as CEUS-positive areas, and confirmed as tumoral areas on histopathological analysis. In 1 case only, CEUS partially failed to demonstrate residual tumor because the residual hyperechoic area was devascularized prior to ultrasound contrast agent injection. In all cases CEUS enhanced B-mode findings. Conc lusions As has already been shown in other neoplastic lesions in other organs, CEUS is extremely specific in the identification of residual tumor. The ability of CEUS to distinguish between tumor and artifacts or normal brain on B-mode is based on its capacity to show the vascularization degree and not the echogenicity of the tissues. Therefore, CEUS can play a decisive role in the process of maximizing GBM resection.",
keywords = "Contrast-enhanced ultrasound, Extent of resection, Glioblastoma, Intraoperative imaging, Intraoperative ultrasound, Residual tumor",
author = "Francesco Prada and {Del Bene}, Massimiliano and Riccardo Fornaro and Vetrano, {Ignazio G.} and Alberto Martegani and Luca Aiani and Sconfienza, {Luca Maria} and Giovanni Mauri and Luigi Solbiati and Bianca Pollo and Francesco DiMeco",
year = "2016",
month = "3",
day = "1",
doi = "10.3171/2015.11.FOCUS15573",
language = "English (US)",
volume = "40",
journal = "Neurosurgical Focus",
issn = "1092-0684",
publisher = "American Association of Neurological Surgeons",
number = "3",

}

TY - JOUR

T1 - Identification of residual tumor with intraoperative contrast-enhanced ultrasound during glioblastoma resection

AU - Prada, Francesco

AU - Del Bene, Massimiliano

AU - Fornaro, Riccardo

AU - Vetrano, Ignazio G.

AU - Martegani, Alberto

AU - Aiani, Luca

AU - Sconfienza, Luca Maria

AU - Mauri, Giovanni

AU - Solbiati, Luigi

AU - Pollo, Bianca

AU - DiMeco, Francesco

PY - 2016/3/1

Y1 - 2016/3/1

N2 - Objective The purpose of this study was to assess the capability of contrast-enhanced ultrasound (CEUS) to identify residual tumor mass during glioblastoma multiforme (GBM) surgery, to increase the extent of resection. Methods The authors prospectively evaluated 10 patients who underwent surgery for GBM removal with navigated ultrasound guidance. Navigated B-mode and CEUS were performed prior to resection, during resection, and after complete tumor resection. Areas suspected for residual tumors on B-mode and CEUS studies were localized within the surgical field with navigated ultrasound and samples were sent separately for histopathological analysis to confirm tumor presence. Results In all cases tumor remnants were visualized as hyperechoic areas on B-mode, highlighted as CEUS-positive areas, and confirmed as tumoral areas on histopathological analysis. In 1 case only, CEUS partially failed to demonstrate residual tumor because the residual hyperechoic area was devascularized prior to ultrasound contrast agent injection. In all cases CEUS enhanced B-mode findings. Conc lusions As has already been shown in other neoplastic lesions in other organs, CEUS is extremely specific in the identification of residual tumor. The ability of CEUS to distinguish between tumor and artifacts or normal brain on B-mode is based on its capacity to show the vascularization degree and not the echogenicity of the tissues. Therefore, CEUS can play a decisive role in the process of maximizing GBM resection.

AB - Objective The purpose of this study was to assess the capability of contrast-enhanced ultrasound (CEUS) to identify residual tumor mass during glioblastoma multiforme (GBM) surgery, to increase the extent of resection. Methods The authors prospectively evaluated 10 patients who underwent surgery for GBM removal with navigated ultrasound guidance. Navigated B-mode and CEUS were performed prior to resection, during resection, and after complete tumor resection. Areas suspected for residual tumors on B-mode and CEUS studies were localized within the surgical field with navigated ultrasound and samples were sent separately for histopathological analysis to confirm tumor presence. Results In all cases tumor remnants were visualized as hyperechoic areas on B-mode, highlighted as CEUS-positive areas, and confirmed as tumoral areas on histopathological analysis. In 1 case only, CEUS partially failed to demonstrate residual tumor because the residual hyperechoic area was devascularized prior to ultrasound contrast agent injection. In all cases CEUS enhanced B-mode findings. Conc lusions As has already been shown in other neoplastic lesions in other organs, CEUS is extremely specific in the identification of residual tumor. The ability of CEUS to distinguish between tumor and artifacts or normal brain on B-mode is based on its capacity to show the vascularization degree and not the echogenicity of the tissues. Therefore, CEUS can play a decisive role in the process of maximizing GBM resection.

KW - Contrast-enhanced ultrasound

KW - Extent of resection

KW - Glioblastoma

KW - Intraoperative imaging

KW - Intraoperative ultrasound

KW - Residual tumor

UR - http://www.scopus.com/inward/record.url?scp=84963657415&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84963657415&partnerID=8YFLogxK

U2 - 10.3171/2015.11.FOCUS15573

DO - 10.3171/2015.11.FOCUS15573

M3 - Article

C2 - 26926065

AN - SCOPUS:84963657415

VL - 40

JO - Neurosurgical Focus

JF - Neurosurgical Focus

SN - 1092-0684

IS - 3

M1 - E7

ER -